港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

荃信生物-B

21.040

+0.6803.34%

成交量：61.26萬

成交額：1,311.31萬

市值：47.78億

市盈率：-12.57

高：22.120

開：20.880

低：20.200

收：20.360

52周最高：36.500

52周最低：5.950

股本：2.27億

香港流通股本：2.27億

量比：0.64

換手率：0.27%

股息：- -

股息率：- -

每股收益(LYR):-1.674

淨資產收益率：-68.26%

總資產收益率：-10.67%

市淨率：19.28

市盈率(LYR):-12.57

市銷率: 13.62

資料載入中...

總覽公司新聞資訊公告

【券商聚焦】中郵證券首予荃信生物(02509)「增持」評級指公司的成熟管線逐步邁入兑現期提升造血能力

荃信生物-B盤中異動下午盤急速拉昇5.19%報25.140港元

荃信生物－Ｂ(02509)股價大幅下跌15.391%，現價港幣$22.1

阿斯达克财经

荃信生物-B(02509)完成配售500萬股

生物醫藥B類股午後漲幅擴大，基石藥業漲超12%，加科思、荃信生物漲超9%

老虎资讯综合

港股異動 | 荃信生物-B(02509)再漲超13% 上半年業績大幅增長近期獲得TruMed基金重金入股

從單抗到雙抗，從國內到海外：荃信生物（02509）如何成為自免賽道新標杆？

港股異動 | 荃信生物-B(02509)漲幅擴大逾22% 上半年營收激增且大幅減虧核心產品研發進展順利

智通财经网

荃信生物折讓11%配股籌1億港元

荃信生物-B(02509)擬折讓約10.95%配售500萬股配售股份淨籌約9900萬港元

荃信生物-B(02509)發佈中期業績，收入2.06億元同比增長359.69%

荃信生物-B(02509)指定馮志偉擔任首席獨立非執行董事

港股生物醫藥概念股強勢拉昇，中慧生物-B、北海康成-B漲超30%

老虎资讯综合

荃信生物-B08月12日主力淨流出34.9萬元散户資金買入

荃信生物-B盤中異動早盤快速跳水5.36%報19.590港元

司美格魯肽上半年銷售額167億美元，鎖定藥王寶座；百濟神州上半年淨利潤4.5億元

Ofweek维科网

荃信生物-B盤中異動早盤快速下挫5.06%

智通港股早知道 | 國辦發文今秋起免除公辦幼兒園學前一年保教費美國未來或宣佈藥品和芯片關税

荃信生物-B(02509)：QX004N進入III期臨牀試驗及收到翰森製藥的付款

荃信生物-B擬8月15日舉行董事會會議批准中期業績

格隆汇资讯

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02509/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":21.04,"timestamp":1763107691009,"preClose":20.36,"halted":0,"volume":612617,"delay":0,"floatShares":227071600,"shares":227071600,"eps":-1.6741456799403034,"marketStatus":"休市中","change":0.68,"latestTime":"11-14 16:08:11","open":20.88,"high":22.12,"low":20.2,"amount":13113144,"amplitude":0.094303,"askPrice":21.08,"askSize":800,"bidPrice":21.04,"bidSize":4200,"shortable":3,"etf":0,"ttmEps":-0.9454174295419391,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763343000000},"marketStatusCode":7,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":20.36,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":0.6413424727535062,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":227071600,"roa":"-10.67%","roe":"-68.26%","lyrEps":-1.674146,"volumeRatio":0.6413424727535062,"shares":227071600,"dividePrice":0,"high":22.12,"amplitude":0.094303,"preClose":20.36,"low":20.2,"week52Low":5.95,"pbRate":"19.28","psRate":"13.62","week52High":36.5,"institutionHeld":0,"latestPrice":21.04,"committee":0.68,"eps":-1.6741456799403034,"divideRate":0,"volume":612617,"delay":0,"ttmEps":-0.9454174295419391,"open":20.88,"prevYearClose":7.38,"prevWeekClose":19.25,"prevMonthClose":21.78,"prevQuarterClose":34.88,"fiveDayClose":19.25,"twentyDayClose":28.5,"sixtyDayClose":24.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"盤後","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2025-11-13","current":-22.257383,"percent":0.137931,"low":-38.274716,"twenty":-12.407907,"median":-9.107782,"eighty":-5.151718,"high":-3.10587,"avg":-11.138615,"sd":8.258911,"marketCap":4610921056},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-17","current":-31.02267,"twenty":-11.536491,"median":-9.052042,"eighty":-5.060821,"marketCap":6489706328},{"date":"2025-10-24","current":-25.824743,"twenty":-11.67702,"median":-9.080681,"eighty":-5.119056,"marketCap":5404304080},{"date":"2025-10-31","current":-23.597698,"twenty":-11.854109,"median":-9.087898,"eighty":-5.129572,"marketCap":4945619448},{"date":"2025-11-07","current":-20.869587,"twenty":-12.197299,"median":-9.096784,"eighty":-5.138538,"marketCap":4371128300},{"date":"2025-11-13","current":-21.952253,"twenty":-12.407907,"median":-9.107782,"eighty":-5.151718,"marketCap":4610921056}],"updateTime":1763147523756},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564632464","title":"【券商聚焦】中郵證券首予荃信生物(02509)「增持」評級 指公司的成熟管線逐步邁入兑現期提升造血能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2564632464","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564632464?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 16:01","pubTimestamp":1756972860,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中邮证券发研报指，荃信生物 发布25年中期业绩公告，25H1公司收入2.06亿元，同比增长348%，期内亏损3093万元，同比收窄83%。根据公司公告，截至2025年6月30日公司收入2.06亿元，包括1)QX030N的海外授权首付款及Caldera Therapeutics的股权非现金代价、QX004NIII期首例入组的里程碑款，合计1.81亿元的授权收入；2)CDMO等服务收入约2200万元。该机构表示，早期管线未入临床已达成 BD，看好公司自免双抗持续出海QX030N：自免双抗，靶点尚未公布。首次覆盖，给予“增持”评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1965536","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","02509"],"gpt_icon":0},{"id":"2564432362","title":"荃信生物-B盤中異動 下午盤急速拉昇5.19%報25.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564432362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564432362?lang=zh_tw&edition=fundamental","pubTime":"2025-09-03 13:23","pubTimestamp":1756876986,"startTime":"0","endTime":"0","summary":"2025年09月03日下午盘13时23分，荃信生物-B股票出现波动，股价大幅拉升5.19%。截至发稿，该股报25.140港元/股，成交量50.18万股，换手率0.22%，振幅6.61%。荃信生物-B股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，创胜集团-B、圣诺医药-B、三叶草生物-B涨幅较大，振幅较大的相关个股有创胜集团-B、三叶草生物-B、圣诺医药-B，振幅分别为31.41%、25.62%、23.26%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903132306a70ce120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250903132306a70ce120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2562702376","title":"荃信生物－Ｂ(02509)股價大幅下跌15.391%，現價港幣$22.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2562702376","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562702376?lang=zh_tw&edition=fundamental","pubTime":"2025-08-28 13:20","pubTimestamp":1756358400,"startTime":"0","endTime":"0","summary":"[下跌股]荃信生物－Ｂ(02509) 股价在下午01:20比前收市价大幅下跌15.391%，现股价为港币$22.1。至目前为止，今日最高价为$26.22，而最低价为$22.1。总成交量为50.42万股，总成交金额为港币$1.234千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2508283065/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2562325247","title":"荃信生物-B(02509)完成配售500萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562325247","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562325247?lang=zh_tw&edition=fundamental","pubTime":"2025-08-25 21:33","pubTimestamp":1756128831,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，配售协议所载的所有条件已获达成，而配售事项完成已根据配售协议的条款于2025年8月25日落实。根据配售协议的条款及条件，配售代理已成功按配售价每股配售股份20.0港元向一名承配人(即TruMed Health Innovation Fund LP)配售合共500万股配售股份，占(i)紧接配售事项完成前已发行股份数目约2.25%;及(ii)紧随配售事项完成后经配发及发行配售股份扩大后的已发行股份数目约2.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1120207642","title":"生物醫藥B類股午後漲幅擴大，基石藥業漲超12%，加科思、荃信生物漲超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120207642","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120207642?lang=zh_tw&edition=fundamental","pubTime":"2025-08-21 15:45","pubTimestamp":1755762330,"startTime":"0","endTime":"0","summary":"8月21日（周四）港股$生物(000504)$医药B类股午后涨幅扩大，基石药业涨超12%，$加科思(01167)$、荃信生物涨超9%，$永泰(W05.SI)$生物、欧康维视生物涨超5%","market":"us","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"47add01c0d28b82e51869ce680f813e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","06978","BK1161","150131","02509"],"gpt_icon":0},{"id":"2561454147","title":"港股異動 | 荃信生物-B(02509)再漲超13% 上半年業績大幅增長 近期獲得TruMed基金重金入股","url":"https://stock-news.laohu8.com/highlight/detail?id=2561454147","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561454147?lang=zh_tw&edition=fundamental","pubTime":"2025-08-21 15:43","pubTimestamp":1755762199,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B再涨超13%，年内累计涨幅接近300%。截至发稿，涨9.26%，报27.6港元，成交额4540.43万港元。消息面上，荃信生物中期业绩显示，上半年收入人民币2.06亿元，同比增加359.69%；期内亏损3093.3万元，同比减少83.11%。收入大幅增长主要来源于对外授权项目首付款、里程碑付款和临床研发服务费收入及CDMO收入等。值得注意的是，在近日的配售中，荃信生物获得真脉投资重金入股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"47add01c0d28b82e51869ce680f813e1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1332717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 荃信生物-B(02509)再涨超13% 上半年业绩大幅增长 近期获得TruMed基金重金入股","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2560140634","title":"從單抗到雙抗，從國內到海外：荃信生物（02509）如何成為自免賽道新標杆？","url":"https://stock-news.laohu8.com/highlight/detail?id=2560140634","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560140634?lang=zh_tw&edition=fundamental","pubTime":"2025-08-20 10:47","pubTimestamp":1755658025,"startTime":"0","endTime":"0","summary":"得益于核心产品商业化以及对外BD，上半年荃信生物业绩大幅增长。不仅如此，荃信生物的亏损状况也得到显著改善，期内经调整亏损522.1万元，较去年同期大幅缩减96%。同时，公司也保持稳健的现金流，截至2025年6月30日，荃信生物现金及现金等价物约为5.59亿元。据了解，赛乐信2024年10月获国家药监局批准上市。2025年4月，荃信生物将长效自免双抗QX030N全球权益授予Caldera，获1000万美元首付、24.88%股权、最高5.45亿美元里程碑及分级销售提成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1331944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2560903908","title":"港股異動 | 荃信生物-B(02509)漲幅擴大逾22% 上半年營收激增且大幅減虧 核心產品研發進展順利","url":"https://stock-news.laohu8.com/highlight/detail?id=2560903908","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560903908?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 14:06","pubTimestamp":1755497160,"startTime":"0","endTime":"0","summary":"荃信生物-B午后涨幅扩大逾22%，高见27.7港元创去年9月以来新高。截至发稿，涨22.08%，报27.42港元，成交额5616.09万港元。期内收入主要包括来自授权协议的收入，包括与QX030N海外授权有关的首付款及Caldera Therapeutics约24.88%股权的非现金代价，以及QX004N III期首例入组的里程碑费用，合计1.81亿元；及CDMO服务产生的收入及QX004N和QX008N项目提供研发服务约2200万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-08-18/doc-infmkuna9898349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02509"],"gpt_icon":0},{"id":"2560664973","title":"荃信生物折讓11%配股籌1億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560664973","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560664973?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 09:07","pubTimestamp":1755479234,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2560953978","title":"荃信生物-B(02509)擬折讓約10.95%配售500萬股配售股份 淨籌約9900萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560953978","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560953978?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 07:58","pubTimestamp":1755475104,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 发布公告，于2025年8月18日，公司与配售代理订立配售协议，据此，配售代理有条件同意作为公司的配售代理向一名承配人按配售价每股配售股份20.0港元配售500万股配售股份。待配售事项完成后，并假设所有配售股份成功配售，预期配售事项所得款项净额将约为9900万港元。于2025年上半年，公司产生额外银行借款以支付其研发开支，导致其资产负债率上升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2559191205","title":"荃信生物-B(02509)發佈中期業績，收入2.06億元 同比增長359.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559191205","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559191205?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 21:59","pubTimestamp":1755266363,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 发布截至2025年6月30日止6个月业绩，该集团取得收入人民币2.06亿元，同比增加359.69%;研发开支1.51亿元，同比增加4.25%;期内亏损3093.3万元，同比减少83.11%;每股亏损0.13元。我们的研发开支由截至2024年6月30日止6个月的1.45亿元增加4.25%至截至2025年6月30日止6个月的1.51亿元，其中以权益结算股份支付摊销减少587万元，研发支出增加1204万元，主要为公司临床试验推进导致的临床试验费用增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"荃信生物-B(02509)发布中期业绩，收入2.06亿元 同比增长359.69%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":1},{"id":"2559918981","title":"荃信生物-B(02509)指定馮志偉擔任首席獨立非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2559918981","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559918981?lang=zh_tw&edition=fundamental","pubTime":"2025-08-15 16:47","pubTimestamp":1755247665,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，为采纳高水准的企业管治，董事会已指定独立非执行董事冯志伟先生自2025年8月15日起担任首席独立非执行董事一职。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"1187244558","title":"港股生物醫藥概念股強勢拉昇，中慧生物-B、北海康成-B漲超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187244558","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187244558?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 10:01","pubTimestamp":1755050488,"startTime":"0","endTime":"0","summary":"8月13日，港股生物医药概念股强势拉升，$中慧生物-B(02627)$、$北海康成-B(01228)$涨超30%，$派格生物医药-B(02565)$涨近9%，$荃信生物-B(02509)$涨超6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"eea96c2db952be4ad0141d428041d6b9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","02627","02565","01228","BK1161","09939"],"gpt_icon":0},{"id":"2558610154","title":"荃信生物-B08月12日主力淨流出34.9萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2558610154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558610154?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 16:15","pubTimestamp":1754986540,"startTime":"0","endTime":"0","summary":"08月12日, 荃信生物-B股价跌3.10%，报收20.00元，成交金额448.1万元，换手率0.10%，振幅3.44%，量比0.26。荃信生物-B今日主力资金净流出34.9万元，上一交易日主力净流入259.9万元。该股近5个交易日下跌11.66%，主力资金累计净流出256.8万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入105.4万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812170115a483bcbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812170115a483bcbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2558337366","title":"荃信生物-B盤中異動 早盤快速跳水5.36%報19.590港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558337366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558337366?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 10:09","pubTimestamp":1754878145,"startTime":"0","endTime":"0","summary":"2025年08月11日早盘10时09分，荃信生物-B股票出现波动，股价快速下跌5.36%。截至发稿，该股报19.590港元/股，成交量10.5万股，换手率0.05%，振幅2.95%。资金方面，该股资金流入61.215万港元，流出134.25万港元。荃信生物-B股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，中慧生物-B、北海康成-B、中生北控生物科技涨幅较大，振幅较大的相关个股有北海康成-B、中生北控生物科技、中慧生物-B，振幅分别为36.30%、16.47%、12.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100905a6de9ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100905a6de9ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2557537132","title":"司美格魯肽上半年銷售額167億美元，鎖定藥王寶座；百濟神州上半年淨利潤4.5億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557537132","media":"Ofweek维科网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557537132?lang=zh_tw&edition=fundamental","pubTime":"2025-08-07 15:47","pubTimestamp":1754552852,"startTime":"0","endTime":"0","summary":"/ 04 / 海外药闻1）2025年上半年司美格鲁肽销售额167亿美元，提前锁定药王宝座8月6日，诺和诺德发布2025年上半年财报。司美格鲁肽上半年销售额达到1127.56亿丹麦克朗，约167亿美元。降糖版司美格鲁肽注射液Ozempic销售额645.20亿丹麦克朗，减重版司美格鲁肽注射液Wegovy为368.88亿丹麦克朗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080715495894d51f4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080715495894d51f4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ONC","02509"],"gpt_icon":0},{"id":"2557587639","title":"荃信生物-B盤中異動 早盤快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557587639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557587639?lang=zh_tw&edition=fundamental","pubTime":"2025-08-07 10:45","pubTimestamp":1754534720,"startTime":"0","endTime":"0","summary":"2025年08月07日早盘10时45分，荃信生物-B股票出现波动，股价大幅跳水5.06%。截至发稿，该股报21.000港元/股，成交量18.72万股，换手率0.08%，振幅7.14%。荃信生物-B股票所在的生物技术行业中，整体跌幅为4.21%。其相关个股中，中生北控生物科技、绿竹生物-B、北海康成-B涨幅较大，振幅较大的相关个股有中生北控生物科技、嘉和生物-B、乐普生物-B，振幅分别为16.00%、12.76%、11.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508071045209738b982&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508071045209738b982&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2557483463","title":"智通港股早知道 | 國辦發文今秋起免除公辦幼兒園學前一年保教費 美國未來或宣佈藥品和芯片關税","url":"https://stock-news.laohu8.com/highlight/detail?id=2557483463","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557483463?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 07:48","pubTimestamp":1754437721,"startTime":"0","endTime":"0","summary":"国办：从2025年秋季学期起免除公办幼儿园学前一年在园儿童保育教育费从2025年秋季学期起，免除公办幼儿园学前一年在园儿童保育教育费。对在教育部门批准设立的民办幼儿园就读的适龄儿童，参照当地同类型公办幼儿园免除水平，相应减免保育教育费。政策将3周岁以下婴幼儿全部纳入补贴范围，年补贴总量约千亿元，由中央财政保障。美国将在未来一周内宣布药品和芯片关税，药品关税最终可能高达250%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1326101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","BK1617","YANG","BK1526","BK1529","00763","HSCEI","BK1161","BK4614","BK1607","02509","BK1149","02228","159813","BK1141","BK1506"],"gpt_icon":1},{"id":"2557393468","title":"荃信生物-B(02509)：QX004N進入III期臨牀試驗及收到翰森製藥的付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2557393468","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557393468?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 19:09","pubTimestamp":1754392183,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)公布，公司正在开发用于治疗银屑病(Ps)及克罗恩病(CD)的白介素23p19亚基(IL23p19)抑制剂QX004N。于2024年4月，公司与翰森制药集团有限公司(03692.HK)的全资附属公司翰森(上海)健康科技有限公司就QX004N在中国内地、中国台湾、中国香港及中国澳门的研发、生产及商业化订立独家对外授权协议。公告称，QX004N最近已进入III期临床试验，成为公司管线中第四个成功进入III期阶段的产品。最近，公司已收到翰森制药根据授权协议支付的PsIII期里程碑及其他付款，共计人民币5800万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1583","III","BK1161","BK1589","03692","02509","BK4134"],"gpt_icon":0},{"id":"2557956153","title":"荃信生物-B擬8月15日舉行董事會會議批准中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2557956153","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557956153?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 17:39","pubTimestamp":1754386755,"startTime":"0","endTime":"0","summary":"格隆汇8月5日丨荃信生物-B(02509.HK)公布，公司董事会会议将于2025年8月15日（星期五）举行，藉以（其中包括）考虑及批准集团截至2025年6月30日止的六个月中期业绩及其发布，考虑建议派发中期股息（如有），以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080517392494d0eef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080517392494d0eef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":104,"code":"91000000","status":"200"}]}}